Stockreport

GSK acquires Elsie to unlock oligonucleotide therapeutics [Yahoo! Finance]

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)  (HLN) 
PDF Elsie Biotechnologies has been at the forefront of oligonucleotide therapeutic development, focusing on increasing potency, reducing toxicity, and optimising delivery t [Read more]